Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 17.60 INR
Change Today +0.30 / 1.73%
Volume 5.5K
VSP On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

vista pharmaceuticals ltd (VSP) Snapshot

Open
18.10
Previous Close
17.30
Day High
18.10
Day Low
17.00
52 Week High
02/27/15 - 20.52
52 Week Low
04/2/14 - 3.05
Market Cap
264.0M
Average Volume 10 Days
10.5K
EPS TTM
0.31
Shares Outstanding
15.0M
EX-Date
--
P/E TM
56.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for VISTA PHARMACEUTICALS LTD (VSP)

Related News

No related news articles were found.

vista pharmaceuticals ltd (VSP) Related Businessweek News

No Related Businessweek News Found

vista pharmaceuticals ltd (VSP) Details

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical products. It offers over the counter and prescription generic drug products consisting of tablets, capsules, and liquids covering various therapeutic categories. The company also exports its products. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.

vista pharmaceuticals ltd (VSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vista pharmaceuticals ltd (VSP) Key Developments

Vista Pharmaceuticals Appoints N. V. Chalapathi Rao as Whole Time Director

Vista Pharmaceuticals Ltd. in its board meeting held on February 06, 2015, appointed Mr. N. V. Chalapathi Rao as Whole Time Director of the Company effective February 06, 2015.

Vista Pharmaceuticals Limited, Board Meeting, Feb 06, 2015

Vista Pharmaceuticals Limited, Board Meeting, Feb 06, 2015. Agenda: To appoint Mr. N. V. Chalapathi Rao as Whole Time Director.

Vista Pharmaceuticals Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and First Nine Months Ended December 31, 2014

Vista Pharmaceuticals Limited announced unaudited standalone earnings results for the third quarter and first nine months ended December 31, 2014. For the quarter, the company announced net sales or income from operations of INR 50.606 million compared to nil a year ago. Profit from operations before other income, interest and exceptional items were INR 8.483 million compared to loss from operations before other income, interest and exceptional items of INR 5.730 million a year ago. Profit from ordinary activities before tax was INR 6.920 million compared to loss from ordinary activities before tax of INR 5.486 million a year ago. Net profit was INR 6.920 million or INR 0.46 per basic and diluted share for before and after extraordinary items compared to net loss of INR 5.486 million or INR 0.36 per basic and diluted share for before and after extraordinary items a year ago. For the first nine months, the company announced net sales or income from operations of INR 112.328 million compared to INR 28.697 million a year ago. Profit from operations before other income, interest and exceptional items were INR 12.871 million compared to loss from operations before other income, interest and exceptional items of INR 8.705 million a year ago. Profit from ordinary activities before tax was INR 9.938 million compared to loss from ordinary activities before tax of INR 8.461 million a year ago. Net profit was INR 9.938 million or INR 0.66 per basic and diluted share for before and after extraordinary items compared to net loss of INR 8.461 million or INR 0.56 per basic and diluted share for before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSP:IN 17.60 INR 0.00

VSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lannett Co Inc $66.12 USD -1.59
Mallinckrodt PLC $124.72 USD -1.93
Mylan NV $57.94 USD -1.41
Novartis AG SFr.96.45 CHF +0.30
Ranbaxy Laboratories Ltd 859.80 INR +45.80
View Industry Companies
 

Industry Analysis

VSP

Industry Average

Valuation VSP Industry Range
Price/Earnings 11.8x
Price/Sales 1.6x
Price/Book 2.8x
Price/Cash Flow 8.5x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VISTA PHARMACEUTICALS LTD, please visit www.vistapharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.